BMJ Open (Sep 2021)
Assessing health-related quality of life and health utilities in patients with chronic hepatitis B-related diseases in China: a cross-sectional study
- Meng Zhang,
- Mei Liu,
- Xiao Wang,
- Peng Wang,
- Hua Ye,
- Qi Yu,
- Jianying Zhang,
- Yaoguang Li,
- Zihao Fan,
- Dongqi Shen,
- Xueying Huang,
- Feng Ren,
- Liping Dai,
- Jianxiang Shi,
- Xiaoang Yang,
- Shunxiang Zhang
Affiliations
- Meng Zhang
- Department of Epidemiology and Health Statistics & Henan Key Laboratory for Tumor Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People’s Republic of China
- Mei Liu
- Department of Oncology, Beijing Youan Hospital, Capital Medical University, Beijing, People’s Republic of China
- Xiao Wang
- State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, People’s Republic of China
- Peng Wang
- Department of Epidemiology and Health Statistics & Henan Key Laboratory for Tumor Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People’s Republic of China
- Hua Ye
- Department of Epidemiology and Health Statistics & Henan Key Laboratory for Tumor Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People’s Republic of China
- Qi Yu
- Department of Interventional Radiology, The First Affillated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China
- Jianying Zhang
- Department of Epidemiology and Health Statistics & Henan Key Laboratory for Tumor Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People’s Republic of China
- Yaoguang Li
- Department of Epidemiology and Health Statistics & Henan Key Laboratory for Tumor Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People’s Republic of China
- Zihao Fan
- Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, People’s Republic of China
- Dongqi Shen
- Hepatobiliary and Pancreatic Surgery, The First Affillated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China
- Xueying Huang
- Department of Oncology, Beijing Youan Hospital, Capital Medical University, Beijing, People’s Republic of China
- Feng Ren
- Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, People’s Republic of China
- Liping Dai
- State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, People’s Republic of China
- Jianxiang Shi
- State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, People’s Republic of China
- Xiaoang Yang
- Henan Academy of Medical and Pharmaceutical Sciences & BGI College, Zhengzhou University, Zhengzhou, Henan, People’s Republic of China
- Shunxiang Zhang
- Department of Epidemiology and Health Statistics & Henan Key Laboratory for Tumor Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan, People’s Republic of China
- DOI
- https://doi.org/10.1136/bmjopen-2020-047475
- Journal volume & issue
-
Vol. 11,
no. 9
Abstract
No abstracts available.